| HOME >> BIOLOGY >> TECHNOLOGY |
TABLE 7 TYPES OF NON-RECEPTOR TYROSINE KINASE INHIBITORS 16
CLASSIFICATION BY SITE OF ACTION 17
TABLE 8 CLASSIFICATION OF KINASE INHIBITORS BY SITE OF ACTION 17
CHAPTER 4 REGULATORY ASPECTS 20
TABLE 9 FDA-APPROVED KINASE INHIBITORS, 2008 TO FEBRUARY 2012 20
TABLE 10 EMA-APPROVED KINASE INHIBITORS 2008 TO FEBRUARY 2012 21
TABLE 11 SAFETY ALERTS AND WARNINGS FOR KINASE INHIBITORS 2008 TO FEBRUARY
2012 22
TABLE 12 NEW DRUG APPLICATIONS OF KINASE INHIBITORS 23
MARKET LEADERS AND THEIR PRODUCTS FOR KINASE INHIBITORS 24
TABLE 13 LEADING MANUFACTURERS AND SUPPLIERS OF RECEPTOR TYROSINE KINASE
INHIBITORS 24
TABLE 14 LEADING MANUFACTURERS AND SUPPLIERS OF NON-RECEPTOR TYROSINE
KINASE INHIBITORS 24
TABLE 15 LEADING MANUFACTURERS AND SUPPLIERS OF MULTI-TARGET TYROSINE
KINASE INHIBITORS 24
TABLE 16 LEADING MANUFACTURERS AND SUPPLIERS OF SERINE AND THREONINE
KINASE INHIBITORS 25
TABLE 17 LEADING MANUFACTURERS AND SUPPLIERS OF ANTIBODY KINASE INHIBITORS 25
CHAPTER 5 NEW DEVELOPMENTS 27
(RECEPTOR) TYROSINE KINASE INHIBITORS (TKIS) 27
TABLE 18 CLINICAL TRIALS IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TKIS 27
TABLE 19 CLINICAL TRIALS IN HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)
TKIS 28
TABLE 20 CLINICAL TRIALS IN PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR)
TKIS 28
TABLE 21 CLINICAL TRIALS IN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR
(VEGFR) TKIS 28
(NON-RECEPTOR) TYROSINE KINASE INHIBITORS (TKIS) 29
TABLE 22 CLINICAL TRIALS IN BCR-ABL TYROSINE KINASE INHIBITORS 29
TABLE 23 CLINICAL TRIALS IN JANUS KINASE (JAK) INHIBITORS 29
TABLE 24 CLINICAL TRIALS IN SPLEEN TYROSINE KINASE (SYK) INHIBITORS 29
MULTIKINASE INHIBITORS 30
TABLE 25 CLINICAL TRIALS IN MULTIKINASE INHIBITORS 30
SERINE/THREONINE KINASE INHIBITOR 31
T
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |